Skip to main content
Clinical Trials/CTRI/2021/02/031078
CTRI/2021/02/031078
Active, not recruiting
未知

An exploratory study to evaluate the prevalence of Genetic polymorphism in patients with Cervical disc degeneration suffering from cervical Spondylotic myelopathy and correlation of gene expression: A genomic study in Cohort

Dr Vishal Kumar0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Vishal Kumar
Status
Active, not recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational

Investigators

Sponsor
Dr Vishal Kumar

Eligibility Criteria

Inclusion Criteria

  • The diagnosis of CSM is based on clinical assessment and Magnetic
  • Resonance Imaging (MRI) findings, which is a standard tool for radiological evaluation of
  • CSM patients. There is an increase in signal intensity on T2 weighted images on MRI in the
  • region of cord compression and a decrease in signal intensity on T1 weighted images in
  • regions having Myelomalacia (loss of neural tissue).
  • Patients with CSM presenting to the hospital, who need surgical treatment by anterior
  • approach will be assessed for eligibility and recruited in the study If they fulfill the following
  • inclusion criteria:
  • 1\. Patient of age \>18 yrs. (of either sex).
  • 2\. Patients with symptomatic CSM.

Exclusion Criteria

  • Patients presenting with acute traumatic cervical spine injury to the
  • emergency ââ?¬â?? ATC\-OPD of PGIMER hospital, who need surgical treatment by anterior
  • approach will be assessed for eligibility and recruited in the study If they fulfill the following
  • inclusion criteria:
  • 1\. Patient of age \>18 yrs. (of either sex).
  • 2\. Patients (including pregnant females) with acute traumatic cervical spine injury and needs
  • surgical treatment by anterior approach.
  • 3\. Patient willing/giving consent and fit in pre\-anaesthetic checkup.
  • 4\. Patient willing/giving written informed consent to take part in the study.
  • Patients will be excluded if any one of the following is present:

Outcomes

Primary Outcomes

Not specified

Similar Trials